Buddy Creech

Jens Meiler, Distinguished Research Professor of Chemistry, was named the principal investigator for the project, in cooperation with 14 investigators across eight institutions. The team will work together to use advanced technology, including computational modeling, AI-driven predictions and structural biology, to develop a groundbreaking vaccine against all alphaviruses that offers long-lasting protection. Read More

A Vanderbilt study finds that Moderna’s COVID-19 vaccine is safe and effective in children 6 months to 5 years of age. Read More

Moderna’s COVID-19 vaccine is safe and generates robust immune responses in children ages 6 to 11 years, a national clinical trial co-led by C. Buddy Creech, MD, MPH, has found. Read More

Vanderbilt Chancellor Daniel Diermeier and Provost and Vice Chancellor for Academic Affairs C. Cybele Raver honored 36 scholars from across the university at an endowed chair investiture ceremony on campus March 30. Read More

Three Vanderbilt health care leaders—André L. Churchwell, C. Buddy Creech and Consuelo H. Wilkins—have been recognized by the "Nashville Business Journal" with 2021 Health Care Innovation Awards. The awards “honor those who pushed the region’s signature industry forward and helped protect their communities in uncertain times.” Read More

Three leaders of the Vanderbilt University Medical Center community are among the winners of the Nashville Business Journal’s 2021 Health Care Innovation awards. Read More

Vanderbilt first-year students recently met with Buddy Creech, director of the Vanderbilt Vaccine Research Program and associate professor of pediatrics, for a special virtual chat to answer some of their COVID-19 vaccine questions. Read More

Vanderbilt University Medical Center has begun recruiting up to 250 participants for a Phase 3 clinical trial testing an investigational COVID-19 vaccine candidate developed by the Janssen Pharmaceutical Companies of Johnson & Johnson. Read More

Researchers at Vanderbilt University Medical Center played a key role in the development of remdesivir, the first drug approved by the U.S. Food and Drug Administration for the treatment of COVID-19. Read More

The investigational antiviral drug remdesivir can shorten the time to recovery in adults hospitalized with COVID-19, according to preliminary results of a clinical trial published last month in The New England Journal of Medicine. Read More

Buddy Creech, director, Vanderbilt Vaccine Research Program, is helping lead some of the NIH-funded treatment trials of COVID-19 in hospitalized patients at Vanderbilt University Medical Center. Read More

Vanderbilt researchers led by Buddy Creech are searching for the key to lasting protection against influenza by examining naturally protecting cells found in bone marrow. Read More

Vanderbilt University Medical Center is recruiting volunteers to participate in a national study of an investigational vaccine against the H7N9 influenza virus, also known as “bird flu.” Read More

Researchers at Vanderbilt University Medical Center are leading an international effort to develop a universal influenza vaccine that would protect everyone against all strains of the flu anywhere in the world. Read More

New multicenter research that includes Vanderbilt University Medical Center (VUMC) investigators, could change treatment approaches to simple skin abscesses, infections often caused by Staphylococcus aureus (staph) bacteria. Read More

Researchers at Vanderbilt University Medical Center (VUMC) are leading a multicenter clinical trial to evaluate whether a shorter course of antibiotics — five days instead of 10 — is effective at treating community-acquired pneumonia (CAP) in children who show improvement after the first few days of taking antibiotics. Read More

The National Institutes of Health (NIH) is launching its Voices of the NIH Community website, which features a collection of StoryCorps audio recordings from patients, families, researchers, doctors, nurses, staff and volunteers in both the NIH and Vanderbilt University Medical Center (VUMC) communities. Read More

Buddy Creech, M.D., MPH, associate professor of Pediatrics, has been named director of the Vanderbilt Vaccine Research Program (VVRP) in the Division of Pediatric Infectious Diseases. Read More

The Faculty Senate, the representative and deliberative body of the Vanderbilt faculties, introduces its leadership for 2015-16. Read More

Minutes from the Vanderbilt Faculty Senate’s March 12 meeting are now available online on the Faculty Senate website. Read More